SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

17 Oct 2020 Evaluate
Dr. Reddy's Laboratories has informed that it has enclosed press release titled ‘Dr. Reddy's and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1341.60 -15.25 (-1.12%)
01-Jul-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1341.60
Cipla 1455.35
Zydus Lifesciences 1110.00
Lupin 2402.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: